Pediatric Neuromodulation Comes of Age.
This special issue surveys recent work and underscores the challenges of psychiatric brain stimulation research with child and adolescent populations. The field of child and adolescent psychopharmacology is replete with examples of potential pitfalls in the assumption that "children are little adults." Arguably, younger age portends more neurobiological and descriptive heterogeneity in research pursuits and clinical practice. For existing brain stimulation modalities, there are a paucity of translational models to design studies for youth and no well-studied dosing schemes. The long-term positive and negative effects of neuromodulation interventions in youth are unknown. Inherent pragmatic and ethical limitations often present barriers for participant recruitment and will necessitate innovative approaches to study design and team efforts. These challenges are not insurmountable, and sustained efforts will advance the growing field of pediatric neuromodulation.
1 Department of Psychiatry and Psychology, Mayo Clinic , Rochester, Minnesota.
Paul E
PE
Croarkin
2 Pediatric Neuromodulation Program, Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital , Harvard Medical School, Boston, Massachusetts.
Alexander
A
Rotenberg
D000293:Adolescent; D000367:Age Factors; D002648:Child; D046690:Deep Brain Stimulation / Q000941:ethics / Q000379:methods*; D004599:Electric Stimulation Therapy / Q000941:ethics / Q000379:methods*; D006801:Humans; D001523:Mental Disorders / Q000628:therapy*; D057170:Translational Research, Biomedical